MDB Pharma SRL
MDB Pharma reported total assets of 214,811 € at the end of the 2025 financial year (annual accounts filed with the NBB on 16 Jul 2026).
The score of MDB Pharma shows with a free account.
See the score- Summary? / 5
- Balance sheet strength
- Liquidity
- Repayment capacity
- Profitability
- Trajectory
- Compliance and register
- Position in its sectorvs peers
- Supplier creditat 30 d
- Borrowing capacityborrowable
- Valuationcentral
Visible once signed in: create your account, the 14-day Pro trial is free.
Key figures 2025
Change 2022 → 2025: Equity +361 % Total assets +173 %
Accounts of the company itself (not consolidated).
The full file covers 4 financial years; a free account shows 2. →Deterministic calculation on the filed accounts, no AI. Dispute the score or report an error
MDB Pharma's annual accounts
Filed annual accounts
- Year ended 31 Dec 2025filed on 16 Jul 2026
- Year ended 31 Dec 2024filed on 14 Aug 2025
- Year ended 31 Dec 2023filed on 21 Aug 2024
- Year ended 31 Dec 2022filed on 31 Aug 2023
MDB Pharma's financial analysis
- Solvency88.5%sector median: 44.2%
- Current ratio
- Net margin
- ROE
- Financial debt / EBITDA
- Interest coverage
- Days sales outstanding (DSO)
Management and control of MDB Pharma
MDB Pharma's publications in the Belgian Gazette
Company number, VAT number and registered office
- Company number (CBE)
- 0767.385.410
- VAT number
- BE0767385410
- Peppol
- Registered · 0208:0767385410 · as of 10 Nov 2026
- Legal form
- SRL
- Incorporated
- 22 Apr 2021
- Registered office
- 9000 Ghent
- Latest accounts
- 2025 · filed on 16 Jul 2026
- Activity
- Retail sale of pharmaceutical products (NACE 47730)
MDB Pharma (SRL) has been based in Ghent since 2021, active in: retail sale of pharmaceutical products. For 2025, it reports a net profit of 59,366 € and equity of 190,172 €; its revenue is not published. Its solvency stands at 88.5%, above the median of its sector (44.2%).
Companies similar to MDB Pharma
Companies in the same business, of comparable size and area, outside its group.
- Apotheek Sophie Vandewynckele Retail sale of pharmaceutical products Eeklo · balance sheet 214,484 €
- Pharmasolutions Retail sale of pharmaceutical products Linkebeek · balance sheet 215,436 €
- Pharmacie VAN Elewyck Retail sale of pharmaceutical products Saint-Gilles · balance sheet 215,446 €
- LE Lumeçon Retail sale of pharmaceutical products Brussels · balance sheet 213,394 €
- Phidelta Pharma Retail sale of pharmaceutical products Liège · balance sheet 216,336 €
- Castoro Retail sale of pharmaceutical products Pajottegem · balance sheet 213,183 €
- Amboplus Retail sale of pharmaceutical products Knokke-Heist · balance sheet 212,418 €
- Obiphar Retail sale of pharmaceutical products Frameries · balance sheet 218,848 €
Frequently asked questions about MDB Pharma
What is the revenue of MDB Pharma?
MDB Pharma files its accounts in a format where revenue is optional: it is not published for 2025.
What is the VAT number of MDB Pharma?
In Belgium, the VAT number is the company number prefixed with BE: BE0767385410 for MDB Pharma, if the company is VAT-registered. Its company number (CBE) is 0767.385.410.
Where is the registered office of MDB Pharma?
According to the CBE register, the registered office of MDB Pharma is in 9000 Ghent.
What is the equity of MDB Pharma?
At the close of the 2025 financial year, the equity of MDB Pharma amounts to 190,172 €, a solvency of 88.5% of total assets.
Who manages MDB Pharma?
The register lists 1 active mandates at MDB Pharma. Names and roles are in the full file, with the deeds published in the Belgian Gazette.
The full file of MDB Pharma
Directors and mandates, ownership network, Gazette deeds, ten years of accounts and ratios, Excel export, and Idonis's analysis in one question.
Open the full file →